Wyatt Wright a.k.a (Wyatt The Warrior) is a 9 year-old young man who was diagnosed with Localized Scleroderma (linear) at the age of 8. Wyatt takes 6 ½ tablets a day and a weekly chemo injection. He is also getting ready to have his second knee surgery…
Columns
Spotlight on the Ssc patient: Maria Alice Martins Correia; Geneva, Switzerland For my blog this week, I would like to introduce Alice to you. Alice is without doubt, one of the bravest pioneering patients of the global Ssc community, and whose story personalises…
The 4th Systemic Sclerosis World Congress was held Feb. 18-20 in Lisbon, Portugal, and organized by the World Scleroderma Foundation, which describes itself as “a nonprofit, non-governmental foundation based in Switzerland, which functions as a research organization in favor of patients suffering from scleroderma.” The Foundation’s Mission Statement:…
On Wednesday 2nd March 2016, I had the honour of attending the Rare Disease UK reception for rare diseases at the House of Commons hosted by Liz Kendall MP. This is the fourth time that Liz has hosted the annual reception for recognising rare disease day, which…
I am very excited to make Rare Disease Day 2016Â the focus of my first post for Scleroderma News. What is Rare Disease Day? From Eurordis.org: “Held each year on the last day of February, Rare Disease Day is an annual awareness-raising event coordinated…
Recent Posts
- Anti-CD146 antibodies may signal occupational exposure in SSc: Study
- New SSc drug safely cuts Raynaud’s attack duration, eases symptoms
- Carbon dioxide hand baths may help in SSc-related Raynaud’s, study finds
- More SSc-ILD patients receive early treatment, new study finds
- CD13 levels elevated in scleroderma, but biomarker value unclear
- New lab findings support development of stem cell treatments for SSc-ILD
- Type of immune cell may be key driver of scleroderma scarring: Study
- Abnormal fatty acid metabolism may play role in scleroderma: Analysis
- Cosmetic laser therapy could be repurposed for localized scleroderma
- Antibody levels may help reflect quality of life in people with scleroderma